chr1-35893673-G-A
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_012199.5(AGO1):c.513-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012199.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGO1 | NM_012199.5 | c.513-1G>A | splice_acceptor_variant, intron_variant | Intron 4 of 18 | ENST00000373204.6 | NP_036331.1 | ||
AGO1 | NM_001317122.2 | c.513-1G>A | splice_acceptor_variant, intron_variant | Intron 4 of 18 | NP_001304051.1 | |||
AGO1 | NM_001317123.2 | c.288-1G>A | splice_acceptor_variant, intron_variant | Intron 4 of 18 | NP_001304052.1 | |||
AGO1 | XM_011541236.3 | c.513-1G>A | splice_acceptor_variant, intron_variant | Intron 4 of 18 | XP_011539538.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1457748Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 724712
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); Canonical splice site variant in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.